Home Oncternal Therapeutics

Oncternal Therapeutics

In operation
Post-IPO Round
Cancer Treatment Drug Developer

Basic Information

Oncternal Therapeutics is a clinical-stage oncology company focused on developing therapies for various cancers with unmet medical needs. Oncternal concentrates its drug development efforts on promising but underexplored biological pathways associated with cancer progression.
Oncternal Therapeutics, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2013
investor.relations@oncternal.com